ADAR1 was shown to edit RNA originating from endogenous retroelements in tumor cells and thus inhibited their ability to stimulate MDA5-mediated IFN-I production that is required for the activation of anti-tumor immune responses (271). This evidence concerns the gene ADAR and neoplasm.